Details for New Drug Application (NDA): 203907
✉ Email this page to a colleague
The generic ingredient in DONEPEZIL HYDROCHLORIDE is donepezil hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
Summary for 203907
Tradename: | DONEPEZIL HYDROCHLORIDE |
Applicant: | Sciegen Pharms Inc |
Ingredient: | donepezil hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 203907
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 203907
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203907 | ANDA | ScieGen Pharmaceuticals, Inc. | 50228-139 | 50228-139-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (50228-139-10) |
DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203907 | ANDA | ScieGen Pharmaceuticals, Inc. | 50228-139 | 50228-139-30 | 30 TABLET, FILM COATED in 1 BOTTLE (50228-139-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Oct 29, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Oct 29, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription